HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Transganglionic effects of Nocodazole, a new synthetic microtubule inhibitor, upon the histochemical structure of the spinal upper dorsal horn.

AbstractPerineural application of Nocodazole (R 17934 of Janssen Pharmaceutica), a new synthetic microtubule inhibitor, induces transganglionic degenerative atrophy of central terminals in the spinal cord of the inflicted primary sensory neurons. This drug offers new possibilities for clinical trials aiming to relieve chronic pain by subcutaneous injection of a microtubule inhibitor.
AuthorsZ Porubcsanszki, B Csillik (Affiliation: Department of Anatomy, Albert Szent-Györgyi Medical University, Szeged, Hungary.)
JournalJournal für Hirnforschung (J Hirnforsch) Vol. 33 Issue 2 Pg. 169-71 ( 1992) ISSN: 0021-8359 [Print] GERMANY
PMID1333003 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Nerve Growth Factors
  • Nocodazole
  • Phosphoric Monoester Hydrolases
  • thiamine monophosphatase
Topics
  • Animals
  • Female
  • Ganglia (drug effects, physiology)
  • Histocytochemistry
  • Male
  • Microtubules (drug effects)
  • Nerve Degeneration (drug effects)
  • Nerve Growth Factors (biosynthesis)
  • Nocodazole (pharmacology)
  • Phosphoric Monoester Hydrolases (metabolism)
  • Rats
  • Sciatic Nerve (cytology, drug effects)
  • Spinal Cord (cytology, drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD